7,138
Views
51
CrossRef citations to date
0
Altmetric
Review Articles

A review of phthalate pharmacokinetics in human and rat: what factors drive phthalate distribution and partitioning?

&
Pages 314-329 | Received 16 Jan 2019, Accepted 13 May 2019, Published online: 22 Jun 2019

References

  • Abraham MH, Acree WE. 2015. Physicochemical and biochemical properties for the dialkyl phthalates. Chemosphere. 119:871–880.
  • Albro PW, Corbett JT, Schroeder JL, Jordan S, Matthews HB. 1982. Pharmacokinetics, interactions with macromolecules and species-differences in metabolism of DEHP. Environ Health Perspect. 45:19–25.
  • Albro PW, Hass JR, Peck CC, Jordan ST, Corbett JT, Schroeder J. 1982. Applications of isotope differentiation for metabolic studies with di-(2-ethylhexyl) phthalate. J Environ Sci Health. 17:701–714.
  • Albro PW, Lavenhar SR. 1989. Metabolism of di(2-ethylhexyl)phthalate. Drug Metab Rev. 21:13–34.
  • Alzaga R, Peña A, Bayona JM. 2003. Determination of phthalic monoesters in aqueous and urine samples by solid-phase microextraction-diazomethane on-fibre derivatization-gas chromatography-mass spectrometry. J Sep Sci. 26:87–96.
  • Andersen C, Krais AM, Eriksson AC, Jakobsson J, Londahl J, Nielsen J, Lindh CH, Pagels J, Gudmundsson A, Wierzbicka A. 2018. Inhalation and dermal uptake of particle and gas-phase phthalates-A human exposure study. Environ Sci Technol. 52:12792–12800.
  • Aylward LL, Hays SM, Gagne M, Krishnan K. 2009a. Derivation of biomonitoring equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7). Regul Toxicol Pharmacol. 55:249–258.
  • Aylward LL, Hays SM, Gagne M, Krishnan K. 2009b. Derivation of biomonitoring equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP). Regul Toxicol Pharmacol. 55:259–267.
  • Balaz S, Lukacova V. 1999. A model-based dependence of the human tissue/blood partition coefficients of chemicals on lipophilicity and tissue composition. Quant Struct Activity Relat. 18:361–368.
  • Becker K, Goen T, Seiwert M, Conrad A, Pick-Fuss H, Muller J, Wittassek M, Schulz C, Kolossa-Gehring M. 2009. GerES IV: phthalate metabolites and bisphenol A in urine of German children. Int J Hyg Environ Health. 212:685–692.
  • Buchta C, Bittner C, Hocker P, Macher M, Schmid R, Seger C, Dettke M. 2003. Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis. Transfusion. 43:1115–1120.
  • Buxton ILO, Benet LZ. 2011. Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination, Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York (NY): McGraw-Hill; p. 17–40.
  • Chen L, Zhao Y, Li LX, Chen BH, Zhang YH. 2012. Exposure assessment of phthalates in non-occupational populations in China. Sci Total Environ. 427:60–69.
  • Choi J, Knudsen LE, Mizrak S, Joas A. 2017. Identification of exposure to environmental chemicals in children and older adults using human biomonitoring data sorted by age: results from a literature review. Int J Hyg Environ Health. 220:282–298.
  • Chu I, Villeneuve DC, Secours V, Franklin C, Rock G, Viau A. 1978. Metabolism and tissue distribution of mono-2-ethylhexyl phthalate in the rat. Drug Metab Dispos. 6:146–149.
  • Clewell RA, Kremer JJ, Williams CC, Campbell JL, Andersen ME, Borghoff SJ. 2008. Tissue exposures to free and glucuronidated monobutylyphthalate in the pregnant and fetal rat following exposure to di-n-butylphthalate: evaluation with a PBPK model. Toxicol Sci. 103:241–259.
  • Cousins I, Mackay D. 2000. Correlating the physical-chemical properties of phthalate esters using the ‘three solubility’ approach. Chemosphere. 41:1389–1399.
  • Daniel JW, Bratt H. 1974. The absorption, metabolism and tissue distribution of di(2-ethylhexyl)phthalate in rats. Toxicology. 2:51–65.
  • DeJongh J, Verhaar HJM, Hermens J. 1997. A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans. Arch Toxicol. 72:17–25.
  • [ECHA] European Chemicals Agency. 2018. Information on chemicals. Helsinki, Finland: European Chemicals Agency. [accessed 2018 Nov 6]. https://echa.europa.eu/information-on-chemicals.
  • Eigenberg DA, Bozigian HP, Carter DE, Sipes IG. 1986. Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat. J Toxicol Environ Health. 17:445–456.
  • Elsisi AE, Carter DE, Sipes IG. 1989. Dermal absorption of phthalate diesters in rats. Fundam Appl Toxicol. 12:70–77.
  • [EPA] United States Environmental Protection Agency. 2012. Estimation programs interface suite™ for microsoft® windows, v 4.11. Washington (DC): United States Environmental Protection Agency. [accessed 2018 Aug 22]. https://www.epa.gov/tsca-screening-tools/epi-suitetm-estimation-program-interface.
  • Fay M, Donohue JM, De Rosa C. 1999. ATSDR evaluation of health effects of chemicals. VI. Di(2-ethylhexyl)phthalate. Agency for toxic substances and disease registry. Toxicol Ind Health. 15:651–746.
  • Fiserova-Bergerova V, Diaz ML. 1986. Determination and prediction of tissue-gas partition coefficients. Int Arch Occup Environ Health. 58:75–87.
  • Frederiksen H, Skakkebaek NE, Andersson AM. 2007. Metabolism of phthalates in humans. Mol Nutr Food Res. 51:899–911.
  • Gentry PR, Clewell HJ, Clewell R, Campbell J, Van Landingham C, Shipp AM. 2011. Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalate. Crit Rev Toxicol. 41:1–72.
  • Guo Y, Alomirah H, Cho HS, Minh TB, Mohd MA, Nakata H, Kannan K. 2011. Occurrence of phthalate metabolites in human urine from several Asian countries. Environ Sci Technol. 45:3138–3144.
  • Hines CJ, Hopf NBN, Deddens JA, Calafat AM, Silva MJ, Grote AA, Sammons DL. 2009. Urinary phthalate metabolite concentrations among workers in selected industries: a pilot biomonitoring study. Ann Occup Hyg. 53:1–17.
  • Hopf NB, Berthet A, Vernez D, Langard E, Spring P, Gaudin R. 2014. Skin permeation and metabolism of di(2-ethylhexyl) phthalate (DEHP). Toxicol Lett. 224:47–53.
  • Huygh J, Clotman K, Malarvannan G, Covaci A, Schepens T, Verbrugghe W, Dirinck E, Van Gaal L, Jorens PG. 2015. Considerable exposure to the endocrine disrupting chemicals phthalates and bisphenol-A in intensive care unit (ICU) patients. Environ Int. 81:64–72.
  • Ikeda GJ, Sapienza PP, Couvillion JL, Farber TM, Smith CP, Inskeep PB, Marks EM, Cerra FE, van Loon EJ. 1978. Distribution and excretion of two phthalate esters in rats, dogs and miniature pigs. Food Cosmet Toxicol. 16:409–413.
  • Ikeda GJ, Sapienza PP, Couvillion JL, Farber TM, Vanloon EJ. 1980. Comparative distribution, excretion and metabolism of di-(2-ethylhexyl) phthalate in rats, dogs and miniature pigs. Food Cosmet Toxicol. 18:637–642.
  • Jaeger RJ, Rubin RJ. 1973. Extraction, localization, and metabolism of Di-2-ethylhexyl phthalate from PVC plastic medical devices. Environ Health Perspect. 3:95–102.
  • Johns LE, Ferguson KK, McElrath TF, Mukherjee B, Meeker JD. 2016. Associations between repeated measures of maternal urinary phthalate metabolites and thyroid hormone parameters during pregnancy. Environ Health Perspect. 124:1808–1815.
  • Kademoglou K, Giovanoulis G, Palm-Cousins A, Padilla-Sanchez JA, Magner J, de Wit CA, Collin CD. 2018. In vitro inhalation bioaccessibility of phthalate esters and alternative plasticizers present in indoor dust using artificial lung fluids. Environ Sci Technol Lett. 5:329–334.
  • Kasper-Sonnenberg M, Koch HM, Wittsiepe J, Wilhelm M. 2012. Levels of phthalate metabolites in urine among mother-child-pairs - Results from the Duisburg birth cohort study, Germany. Int J Hyg Environ Health. 215:373–382.
  • Kastury F, Smith E, Juhasz AL. 2017. A critical review of approaches and limitations of inhalation bioavailability and bioaccessibility of metal(loid)s from ambient particulate matter or dust. Sci Total Environ. 574:1054–1074.
  • Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, Golub M, Henderson R, Hinberg I, Little R, et al. 2002a. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of butyl benzyl phthalate. Reprod Toxicol. 16:453–487.
  • Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, Golub M, Henderson R, Hinberg I, Little R, et al. 2002b. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. Reprod Toxicol. 16:529–653.
  • Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, Golub M, Henderson R, Hinberg I, Little R, et al. 2002c. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-isononyl phthalate. Reprod Toxicol. 16:679–708.
  • Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, Golub M, Henderson R, Hinberg I, Little R, et al. 2002d. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-butyl phthalate. Reprod Toxicol. 16:489–527.
  • Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, Golub M, Henderson R, Hinberg I, Little R, et al. 2002e. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-hexyl phthalate. Reprod Toxicol. 16:709–719.
  • Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, Golub M, Henderson R, Hinberg I, Little R, et al. 2002f. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-octyl phthalate. Reprod Toxicol. 16:721–734.
  • Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, Golub M, Henderson R, Hinberg I, Little R, et al. 2002g. NTP center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-isodecyl phthalate. Reprod Toxicol. 16:655–678.
  • Kessler W, Numtip W, Grote K, Csanady GA, Chahoud I, Filser JG. 2004. Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets. Toxicol Appl Pharmacol. 195:142–153.
  • Keys DA, Wallace DG, Kepler TB, Conolly RB. 1999. Quantitative evaluation of alternative mechanisms of blood and testes disposition of di(2-ethylhexyl) phthalate and mono(2-ethylhexyl) phthalate in rats. Toxicol Sci. 49:172–185.
  • Keys DA, Wallace DG, Kepler TB, Conolly RB. 2000. Quantitative evaluation of alternative mechanisms of blood disposition of di(n-butyl) phthalate and mono(n-butyl) phthalate in rats. Toxicol Sci. 53:173–184.
  • Kim MG, Kim TH, Shin BS, Lee YB, Lee JB, Choi HG, Lee Y, Yoo SD. 2015. Sensitive liquid chromatography-tandem mass spectrometry method for the simultaneous determination of benzyl butyl phthalate and its metabolites, monobenzyl phthalate and monobutyl phthalate, in rat plasma, urine, and various tissues collected from a toxicokinetic study. Anal Bioanal Chem. 407:7391–7400.
  • Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han LY, He JE, He SQ, Shoemaker BA, et al. 2016. PubChem substance and compound databases. Nucleic Acids Res. 44:D1202–D1213.
  • Kluwe WM. 1982. Overview of phthalate ester pharmacokinetics in mammalian species. Environ Health Perspect. 45:3–10.
  • Knudsen GA, Sanders JM, Birnbaum LS. 2017. Disposition of the emerging brominated flame retardant, bis(2-ethylhexyl) tetrabromophthalate, in female Sprague Dawley rats: effects of dose, route and repeated administration. Xenobiotica. 47:245–254.
  • Koch HM, Bolt HM, Preuss R, Angerer J. 2005. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol. 79:367–376.
  • Koch HM, Bolt HM, Preuss R, Eckstein R, Weisbach V, Angerer J. 2005. Intravenous exposure to di(2-ethylhexyl)phthalate (DEHP): metabolites of DEHP in urine after a voluntary platelet donation. Arch Toxicol. 79:689–693.
  • Koch HM, Drexler H, Angerer J. 2004. Internal exposure of nursery-school children and their parents and teachers to di(2-ethylhexyl)phthalate (DEHP)). Int J Hyg Environ Health. 207:15–22.
  • Krais AM, Andersen C, Eriksson AC, Johnsson E, Nielsen J, Pagels J, Gudmundsson A, Lindh CH, Wierzbicka A. 2018. Excretion of urinary metabolites of the phthalate esters DEP and DEHP in 16 volunteers after inhalation and dermal exposure. Int J Environ Res Public Health. 15: E2514.
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Int Med. 151:W65–W94.
  • Lu CH. 2009. Prediction of environmental properties in water-soil-air systems for phthalates. Bull Environ Contam Toxicol. 83:168–173.
  • McKee RH, El-Hawari M, Stoltz M, Pallas F, Lington AW. 2002. Absorption, disposition and metabolism of di-isononyl phthalate (DINP) in F-344 rats. J Appl Toxicol. 22:293–302.
  • Mose T, Mortensen GK, Hedegaard M, Knudsen LE. 2007. Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta tissue and umbilical cord blood. Reprod Toxicol. 23:83–91.
  • Murphy JE, Janszen DB, Gargas ML. 1995. An in-vitro method for determination of tissue partition-coefficients of nonvolatile chemicals such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and estradiol. J Appl Toxicol. 15:147–152.
  • [NIH] National Institutes of Health. 2018. US national library of medicine, TOXNET (toxicology data network), ChemIDplus. Bethesda (MD): National Institutes of Health. [accessed 2018 Aug 22]. https://www.ncbi.nlm.nih.gov/pccompound.
  • Payan JP, Marty JP, Fabry JP, Beydon D, Boudry I, Ferrari E, Canel F, Grandclaude MC, Vincent CM. 2001. In vivo and in vitro percutaneous absorption of [(14)C]di-N-butylphthalate in rat. Drug Metab Dispos. 29:843–854.
  • Payne MP, Kenny LC. 2002. Comparison of models for the estimation of biological partition coefficients. J Toxicol Environ Health Part A. 65:897–931.
  • Peyret T, Poulin P, Krishnan K. 2010. A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals. Toxicol Appl Pharmacol. 249:197–207.
  • Poulin P, Krishnan K. 1995a. A biologically-based algorithm for predicting human tissue – blood partition coefficients of organic chemicals. Hum Exp Toxicol. 14:273–280.
  • Poulin P, Krishnan K. 1995b. An algorithm for predicting tissue:blood partition coefficients of organic chemicals from n-octanol:water partition coefficient data. J Toxicol Environ Health. 46:117–129.
  • Poulin P, Schoenlein K, Theil FP. 2001. Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs. J Pharm Sci. 90:436–447.
  • Poulin P, Theil FP. 2000. A Priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J Pharm Sci. 89:16–35.
  • Salim CJ, Liu H, Kennedy JF. 2010. Comparative study of the adsorption on chitosan beads of phthalate esters and their degradation products. Carbohydr Polym. 81:640–644.
  • Schmitt W. 2008. General approach for the calculation of tissue to plasma partition coefficients. Toxicol in Vitro. 22:457–467.
  • Schulz CO, Rubin RJ. 1973. Distribution, metabolism, and excretion of Di-2-ethylhexyl phthalate in the rat. Environ Health Perspect. 3:123–129.
  • Scott RC, Dugard PH, Ramsey JD, Rhodes C. 1987. In vitro absorption of some ortho-phthalate diesters through human and rat skin. Environ Health Perspect. 74:223–227.
  • Sharma RP, Schuhmacher M, Kumar V. 2018. Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and its metabolites: a bottom up modeling approach. Toxicol Lett. 296:152–162.
  • Shintani H. 2000. Pretreatment and chromatographic analysis of phthalate esters, and their biochemical behavior in blood products. Chromatographia. 52:721–726.
  • Silva MJ, Furr J, Preau JL, Samandar E, Gray LE, Calafat AM. 2012. Identification of potential biomarkers of exposure to di(isononyl)cyclohexane-1,2-dicarboxylate (DINCH), an alternative for phthalate plasticizers. J Expo Sci Environ Epidemiol. 22:204–211.
  • Song NR, On JW, Lee J, Park JD, Kwon HJ, Yoon HJ, Pyo H. 2013. Biomonitoring of urinary di(2-ethylhexyl) phthalate metabolites of mother and child pairs in South Korea. Environ Int. 54:65–73.
  • Sugino M, Hatanaka T, Todo H, Mashimo Y, Suzuki T, Kobayashi M, Hosoya O, Jinno H, Juni K, Sugibayashi K. 2017. Safety evaluation of dermal exposure to phthalates: metabolism-dependent percutaneous absorption. Toxicol Appl Pharmacol. 328:10–17.
  • Tanaka A, Adachi T, Takahashi T, Yamaha T. 1975. Biochemical studies on phthalic esters. 1. Elimination, distribution and metabolism of di-(2-ethylhexyl)phthalate in rats. Toxicology. 4:253–264.
  • Wang YP, Zhang GW. 2015. Spectroscopic and molecular simulation studies on the interaction of di-(2-ethylhexyl) phthalate and human serum albumin. Luminescence. 30:198–206.
  • White RD, Carter DE, Earnest D, Mueller J. 1980. Absorption and metabolism of three phthalate diesters by the rat small intestine. Food Cosmet Toxicol. 18:383–386.
  • Williams DT, Blanchfield BJ. 1975. The retention, distribution, excretion, and metabolism of dibutyl phthalate-7-14 C in the rat. J Agric Food Chem. 23:854–858.
  • Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K. 2006. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal. 26:803–824.
  • Xie XY, Wang ZW, Zhou XM, Wang XR, Chen XG. 2011. Study on the interaction of phthalate esters to human serum albumin by steady-state and time-resolved fluorescence and circular dichroism spectroscopy. J Hazard Mater. 192:1291–1298.
  • Yuan D, Shen ZL, Liu RT, Wei PH, Gao CZ. 2014. Toxic interaction between dibutyl phthalate and human serum albumin: spectroscopic and molecular modeling investigations. J Chin Chem Soc. 61:255–262.
  • Yue YY, Liu JM, Liu R, Sun YY, Li XG, Fan J. 2014. The binding affinity of phthalate plasticizers-protein revealed by spectroscopic techniques and molecular modeling. Food Chem Toxicol. 71:244–253.
  • Zhao HZ, Li JF, Zhou YQ, Zhu L, Zheng YY, Xia W, Li YY, Xiang L, Chen W, Xu SQ, et al. 2018. Investigation on metabolism of di(2-ethylhexyl) phthalate in different trimesters of pregnant women. Environ Sci Technol. 52:12851–12858.
  • Zota AR, Calafat AM, Woodruff TJ. 2014. Temporal trends in phthalate exposures: findings from the national health and nutrition examination survey, 2001–2010. Environ Health Perspect. 122:235–241.